Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intranasal Fentanyl to Reduce Pain Intensity Associated With Retinopathy of Prematurity Screening in Preterm Infants: A Randomized Control Trial

NCT07112430 is registered in ClinicalTrials.gov with Marsha Campbell-Yeo as lead sponsor.

NCT NCT07112430
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07112430 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intranasal Fentanyl to Reduce Pain Intensity Associated With Retinopathy of Prematurity Screening in Preterm Infants: A Randomized Control Trial
Lead sponsor
Marsha Campbell-Yeo
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
September 9, 2026
Completion date
June 1, 2028
Enrollment
58 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

analgesia, fentanyl, infant, newborn, infant, premature, intranasal drug administration, neonatal intensive care units, neonatal pain, pain management, retinopathy of prematurity (rop)